The Mary Kay FoundationSM recently announced its 2018 cancer grant recipients.
The Foundation awards grants annually to top research institutions in the US that are conducting innovative research to better understand cancers that affect women. Since 1996, the Foundation has awarded more than $28 million in grants to universities and medical centers around the country.
With cancer being the second-leading cause of death in women, the Foundation has made it a priority to support research of cancers affecting women at US medical schools and research facilities. After reviewing more than 160 applications, the Research Review Committee awarded $100,000 grants to 12 leading cancer research institutions:
- Dana-Farber Cancer Institute at Harvard Medical School
- Vanderbilt University Medical Center
- Rutgers New Jersey Medical School
- University of Texas Southwestern Medical Center
- UPMC Hillman Cancer Center
- Weill Cornell Medicine
- Washington University in St. Louis
- University of North Carolina Lineberger Comprehensive Cancer Center
- University of Wisconsin – Madison
- UCLA’s Jonsson Comprehensive Cancer Center
- University of North Dakota
- University of Chicago
“We have seen previous grants lead to innovative breakthroughs in the study of breast, uterine, cervical and ovarian cancers and are thrilled with this year’s recipients,” said Michael Lunceford, president of The Mary Kay Foundation Board of Directors. “The Foundation’s commitment to cancer research is anchored by our founder’s legacy and carried on by the passion and support of our company and independent sales force to someday find a cure. By continuing support for these scientists and institutions we know we are continuing to better and enrich the lives of women everywhere.”
